Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2009-10-31
2012-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Motivational Interviewing Intervention for Intimate Partner Violence
NCT01410669
Promoting Attachment Through Healing
NCT03536442
Guided Self-help Following Sexual Assault - SCED
NCT05717023
Experiences of Psychotherapeutic Outcomes in Women Victims of Domestic Violence
NCT06190106
Intervention Program With Perpetrators of Intimate Partner Violence
NCT05484440
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
providing information sheet
providing participants with information regarding the purpose of the research
Information Sheet
Providing the Participant with information regarding the aim of the experiment
Seeking consent
Consent
Providing a consent form for participants. The participant is aware of his or her rights
Interview Participant
interview
participants will interviewed by fardin jussab for approximately one hour regarding their experience of client violence
Debrief
The Participants will be debriefed after the interview.
Debrief
at the end of each interview the researcher will ask participants whether the emotions aroused in the interview require further discussions. Interviewees will be also advised that should they wish to talk further about any topics covered the in the interview, they could telephone the researcher at a later time. There will also be leaflets of supporting agencies.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Information Sheet
Providing the Participant with information regarding the aim of the experiment
Consent
Providing a consent form for participants. The participant is aware of his or her rights
interview
participants will interviewed by fardin jussab for approximately one hour regarding their experience of client violence
Debrief
at the end of each interview the researcher will ask participants whether the emotions aroused in the interview require further discussions. Interviewees will be also advised that should they wish to talk further about any topics covered the in the interview, they could telephone the researcher at a later time. There will also be leaflets of supporting agencies.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
24 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of East London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fardin Jussab
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Helen Murphy, BA, MSc, DPhil
Role: STUDY_CHAIR
University of East London
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Health Service
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UEL1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.